Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE)

Es posible que algunos contenidos no estén disponibles en español.

Summary

The purpose of ADAPTABLE was to find the best dose of aspirin, 81 mg or 325 mg, for people with known or existing heart disease to prevent death or another heart attack or stroke.

Study Details

Conditions
Heart and Circulation
Investigators
William S. Jones, MD
Adrian F. Hernandez, MD MHS FAHA